Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Zacks.com on MSN1d
Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com on MSN7h
Here's Why Guardant Health (GH) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Guardant Health (GH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate ...
Business Wire4d
Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...
Investing4d
Bernstein maintains Guardant Health outperform on debt deal
On Monday, Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its ...
Bernstein maintains Guardant Health outperform on debt deal
Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its convertible notes ...